Written and maintained by CASRAI Editorial Board
Last updated
The Sequential Organ Failure Assessment (SOFA) score—originally introduced in 1996 by the Working Group on “Sepsis-Related Problems” of the European Society of Intensive Care Medicine (ESICM) (Vincent et al., Intensive Care Medicine 1996;22(7):707–710) as the Sepsis-related Organ Failure Assessment—is an objective, six-organ clinical scoring system used in intensive care units (ICUs) and critical care clinical trials to quantify the severity and daily trajectory of acute organ dysfunction.
What Is the SOFA Score and How Is It Used in Clinical Research and Healthcare?
Unlike admission-only severity models such as the APACHE II score, comorbidity indices such as the Charlson Comorbidity Index, or disease-specific prognostic tools such as the Ranson Criteria and TIMI Score, the SOFA score is designed for serial calculation every 24 hours using the most abnormal physiological and laboratory value recorded in each of six organ systems during the preceding 24-hour window.
Each of the six organ systems is scored from 0 (normal function) to 4 (most severe dysfunction), yielding a composite total SOFA score ranging from 0 to 24 points:
| Organ System (Parameter) | 0 Points | 1 Point | 2 Points | 3 Points | 4 Points |
|---|---|---|---|---|---|
| Respiration PaO₂/FiO₂, mmHg (kPa) |
≥ 400 (53.3) |
< 400 (53.3) |
< 300 (40) |
< 200 (26.7) with respiratory support | < 100 (13.3) with respiratory support |
| Coagulation Platelets, ×10³/μL |
≥ 150 | < 150 | < 100 | < 50 | < 20 |
| Liver Bilirubin, mg/dL (μmol/L) |
< 1.2 (< 20) |
1.2–1.9 (20–32) |
2.0–5.9 (33–101) |
6.0–11.9 (102–204) |
> 12.0 (> 204) |
| Cardiovascular MAP or vasopressors (μg/kg/min for ≥ 1 h) |
MAP ≥ 70 mmHg | MAP < 70 mmHg | Dopamine ≤ 5 or dobutamine (any dose) | Dopamine > 5 OR epinephrine ≤ 0.1 OR norepinephrine ≤ 0.1 | Dopamine > 15 OR epinephrine > 0.1 OR norepinephrine > 0.1 |
| Central Nervous System Glasgow Coma Scale (GCS) |
15 | 13–14 | 10–12 | 6–9 | < 6 |
| Renal Creatinine, mg/dL (μmol/L) or Urine Output |
< 1.2 (< 110) |
1.2–1.9 (110–170) |
2.0–3.4 (171–299) |
3.5–4.9 (300–440) or < 500 mL/day |
> 5.0 (> 440) or < 200 mL/day |
What Standards or Regulatory Requirements Govern the SOFA Score? Sepsis-3 Operational Definitions
In February 2016, the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM) published the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) (Singer et al., JAMA 2016;315(8):801–810), which replaced the 1991/2001 Systemic Inflammatory Response Syndrome (SIRS) criteria and formally anchored the clinical definition of sepsis to the SOFA score:
- Sepsis-3 Operational Criteria for Sepsis: Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Clinically, organ dysfunction is identified as an acute increase in total SOFA score of ≥ 2 points consequent to the infection. In a general hospital population with suspected infection, a ΔSOFA ≥ 2 points reflects an overall mortality risk of approximately 10% or greater. For patients with no known preexisting organ dysfunction, the baseline SOFA score is assumed to be zero.
- Septic Shock Operational Criteria: A subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality (>40%), clinically identified by persistent hypotension requiring vasopressors to maintain a Mean Arterial Pressure (MAP) ≥ 65 mmHg AND a serum lactate level > 2 mmol/L (18 mg/dL) despite adequate volume resuscitation.
- qSOFA (Quick SOFA) vs. Full SOFA and Surviving Sepsis Campaign Guidelines: Sepsis-3 also introduced qSOFA (1 point each for respiratory rate ≥ 22/min, altered mentation [GCS < 15], and systolic blood pressure ≤ 100 mmHg; positive at ≥ 2 points) as a laboratory-free bedside prompt outside the ICU. However, the 2021 Surviving Sepsis Campaign International Guidelines explicitly recommend against using qSOFA compared with SIRS, NEWS, or MEWS as a single standalone screening tool for sepsis due to its lower sensitivity for early detection, reserving the full 6-organ SOFA score to characterize organ dysfunction.
- Clinical Trial Endpoints (ΔSOFA): In Phase II and Phase III randomized controlled trials of novel sepsis therapeutics, immunomodulators, and extracorporeal organ support devices reviewed by the FDA and EMA, change in SOFA score (ΔSOFA) over fixed intervals (such as Day 1 to Day 7) and organ-failure-free days serve as validated intermediate clinical endpoints alongside 28-day all-cause mortality.
How Does the SOFA Score Integrate with EHR and Health Informatics Workflows?
Because manual calculation of all six SOFA sub-scores requires pulling data from blood gas analyzers, hematology/chemistry laboratory feeds, nursing flowsheets, and medication infusion pumps, modern hospitals automate SOFA computation inside the EHR and clinical research databases:
- Automated EHR Clinical Decision Support (CDS) Calculators: Enterprise EHRs continuously ingest LOINC-coded laboratory results (arterial PaO₂, platelet count, total bilirubin, and serum creatinine), nursing flowsheet observations (GCS, MAP, FiO₂, mechanical ventilation status, and 24-hour urine output), and smart infusion pump rates (weight-based norepinephrine, epinephrine, dopamine, and dobutamine dosing in μg/kg/min) to compute a rolling 24-hour worst-value SOFA score and trigger sepsis alerts when ΔSOFA ≥ 2.
- SpO₂/FiO₂ (S/F Ratio) Imputation in Non-ICU Settings: When an arterial blood gas (PaO₂) is not available in ward or emergency department patients, validated EHR algorithms and pragmatic critical care trials (such as Rice et al., Chest 2007) impute the respiratory SOFA sub-score using the non-invasive pulse oximetry SpO₂/FiO₂ ratio.
- OMOP CDM and MIMIC-IV Research Pipelines: In open critical care datasets (such as MIMIC-IV and eICU-CRD) and multi-site OMOP Common Data Model repositories, standardized SQL concept sets extract hourly SOFA trajectories to risk-adjust observational comparative effectiveness studies.
Frequently Asked Questions
What is the SOFA score and how is it used in clinical research and healthcare?
The Sequential Organ Failure Assessment (SOFA) score is a 0-to-24-point clinical scoring matrix that grades dysfunction from 0 to 4 across six organ systems: Respiration (PaO₂/FiO₂), Coagulation (platelets), Liver (bilirubin), Cardiovascular (MAP and vasopressor doses), Central Nervous System (Glasgow Coma Scale), and Renal (creatinine or urine output). It is used in ICUs to track daily organ failure progression and in clinical trials as an inclusion criterion and intermediate efficacy endpoint (ΔSOFA).
What standards or regulatory requirements govern the SOFA score?
Under the 2016 Sepsis-3 International Consensus Definitions (Singer et al., JAMA 2016) and the Surviving Sepsis Campaign guidelines, an acute increase in total SOFA score of ≥ 2 points consequent to infection is the operational clinical criterion defining sepsis.
How does the SOFA score integrate with EHR and health informatics workflows?
EHR clinical decision support engines and HL7 FHIR R4 pipelines automatically calculate rolling 24-hour SOFA scores by aggregating LOINC-coded lab values (platelets, bilirubin, creatinine, PaO₂), nursing flowsheet vitals (MAP, GCS, FiO₂, urine output), and weight-based vasopressor infusion rates from smart pumps to flag acute ≥ 2-point increases.
